Press Releases

Date	Title	Company
27-Sep-2023	Image Guided Systems Market: Illuminating Medical Horizons, Targeting US$ 17.41 Billion by 2033	MARKITWIRED
27-Sep-2023	Ten sustainable choices for the eco-conscious scientist	Scientific Lab Supplies
27-Sep-2023	Continuous Glucose Monitoring Devices Market is Expected to Experience Significant Growth in the Coming Years, With a Projected to Value of US$ 16.8 Billion By 2033	MARKITWIRED
27-Sep-2023	Cell and Gene Therapy Manufacturing Market To Embark On A 29% CAGR Expedition from 2023 to 2033, As Predicted By FMI	MARKITWIRED
27-Sep-2023	Aquaculture Vaccine Market Poised to reach US$ 913.6 Million by 2033, Fuelled by Rising Global Aquaculture Production: FMI Study	MARKITWIRED
27-Sep-2023	Encephalitis Management Market Envisioned to Exceed US$ 34.08 Billion by 2033, Driven by Advances in Encephalitis Recovery \| FMI	MARKITWIRED
27-Sep-2023	Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy	Evotec SE
27-Sep-2023	Synergistic Approaches and Innovative Assays Are Poised To Drive the Complicated Urinary Tract Infection Treatment Market at a CAGR Of 5.76%, As Per FMI	MARKITWIRED
27-Sep-2023	Generalized Myasthenia Gravis (GMG) Managements Market to Reach a Valuation of US$ 2.96 Billion by 2033 Due to Growing Geriatric Population Globally	MARKITWIRED
27-Sep-2023	Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa	Cosmo Pharmaceuticals N.V.
27-Sep-2023	Increasing Demand for Frontotemporal Dementia Management to Propel the Growth at 6% CAGR through 2033: FMI Study	MARKITWIRED
27-Sep-2023	Global Market for Tuberculous Meningitis Treatment to expand at a 7.2% CAGR from 2023 to 2033, reaching US$ 300 Billion: FMI Report	MARKITWIRED
27-Sep-2023	Idiopathic Pulmonary Fibrosis Management Market to Reach US$ 3649.90 Million by 2033: Focus on Developing New Drugs and Therapies \| FMI	MARKITWIRED
26-Sep-2023	Alpha-1 Antitrypsin Deficiency Market Booms to US$10 Billion by 2033, Propelled by a Noteworthy 12.8% CAGR \| FMI Report	MARKITWIRED
26-Sep-2023	FMI Reveals Remarkable Forecast for the Chronic Obstructive Pulmonary Disease (COPD): Expected to Reach US$33.19 Billion with a 4.4% CAGR by 2033	MARKITWIRED
26-Sep-2023	AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer’s conference	AlzeCure
26-Sep-2023	Oncopeptides announces successful price negotiations for Pepaxti in Germany	Oncopeptides AB
26-Sep-2023	UCB announces approval of RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in Japan	UCB
26-Sep-2023	XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke	XBiotech Inc.
26-Sep-2023	Northern Gritstone and Argobio Studio back Sheffield University spin-out Crucible Therapeutics	Crucible Therapeutics